Search results: Sage Journals

Open accessResearch articleFirst published 2021

Resting-state connectivity studies as a marker of the acute and delayed effects of subanaesthetic ketamine administration in healthy and depressed individuals: A systematic review

Vasileia Kotoula, Toby Webster, James Stone [...]

Brain and Neuroscience Advances

Open accessResearch articleFirst published 2020

Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study

Paul Glue, Natalie J. Medlicott, Shona Neehoff [...]

Therapeutic Advances in Psychopharmacology

Restricted accessResearch articleFirst published April, 2021

Delayed Onset of Central Diabetes Insipidus With Ketamine Sedation: A Report of 2 Cases

Leah B. Herity, Cassandra Baker, Christin Kim [...]

Journal of Pharmacy Practice

Restricted accessResearch articleFirst published July, 2013

Two cases of delayed-onset suicidal ideation,dysphoria and anxiety after ketamine infusion in patients with obsessive–compulsive disorder and a history of major depressive disorder

Mark J Niciu, Beth DG Grunschel, Philip R Corlett [...]

Journal of Psychopharmacology

Open accessReview articleFirst published 2019

Novel Targets for Fast Antidepressant Responses: Possible Role of Endogenous Neuromodulators

Anderson Camargo, Ana Lúcia S. Rodrigues

Chronic Stress

Open accessResearch articleFirst published 2020

Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers

Dmitriy Matveychuk, Rejish K. Thomas, Jennifer Swainson [...]

Therapeutic Advances in Psychopharmacology

Restricted accessResearch articleFirst published February, 2024

Ensuring the affordable becomes accessible–lessons from ketamine,a new treatment for severe depression

Anthony Rodgers, Dilara Bahceci, Christopher G Davey [...]

Australian & New Zealand Journal of Psychiatry

Restricted accessOtherFirst published November, 2008

Intravenous Ketamine “Burst” for Refractory Depression in a Patient with Advanced Cancer

Lilianna Stefanczyk-Sapieha, Doreen Oneschuk, Michael Demas

Journal of Palliative Medicine

Free accessResearch articleFirst published November, 2018

Ketamine and rapidly acting antidepressants: Breaking the speed of sound or light?

Michael Berk, Collen Loo, Christopher G Davey [...]

Australian & New Zealand Journal of Psychiatry

Open accessReview articleFirst published 2026

Patient-centred education for ketamine and esketamine therapies in mood disorders

Zofia Kachlik, Wiesław Jerzy Cubała, Michał Walaszek

Therapeutic Advances in Psychopharmacology

Open accessResearch articleFirst published 2021

Resting-state connectivity studies as a marker of the acute and delayed effects of subanaesthetic ketamine administration in healthy and depressed individuals: A systematic review

Vasileia Kotoula, Toby Webster, James Stone [...]

Brain and Neuroscience Advances

Open accessResearch articleFirst published 2020

Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study

Paul Glue, Natalie J. Medlicott, Shona Neehoff [...]

Therapeutic Advances in Psychopharmacology

Restricted accessResearch articleFirst published April, 2021

Delayed Onset of Central Diabetes Insipidus With Ketamine Sedation: A Report of 2 Cases

Leah B. Herity, Cassandra Baker, Christin Kim [...]

Journal of Pharmacy Practice

Restricted accessResearch articleFirst published July, 2013

Two cases of delayed-onset suicidal ideation,dysphoria and anxiety after ketamine infusion in patients with obsessive–compulsive disorder and a history of major depressive disorder

Mark J Niciu, Beth DG Grunschel, Philip R Corlett [...]

Journal of Psychopharmacology

Open accessReview articleFirst published 2019

Novel Targets for Fast Antidepressant Responses: Possible Role of Endogenous Neuromodulators

Anderson Camargo, Ana Lúcia S. Rodrigues

Chronic Stress

Open accessResearch articleFirst published 2020

Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers

Dmitriy Matveychuk, Rejish K. Thomas, Jennifer Swainson [...]

Therapeutic Advances in Psychopharmacology

Restricted accessResearch articleFirst published February, 2024

Ensuring the affordable becomes accessible–lessons from ketamine,a new treatment for severe depression

Anthony Rodgers, Dilara Bahceci, Christopher G Davey [...]

Australian & New Zealand Journal of Psychiatry

Restricted accessOtherFirst published November, 2008

Intravenous Ketamine “Burst” for Refractory Depression in a Patient with Advanced Cancer

Lilianna Stefanczyk-Sapieha, Doreen Oneschuk, Michael Demas

Journal of Palliative Medicine

Free accessResearch articleFirst published November, 2018

Ketamine and rapidly acting antidepressants: Breaking the speed of sound or light?

Michael Berk, Collen Loo, Christopher G Davey [...]

Australian & New Zealand Journal of Psychiatry

Open accessReview articleFirst published 2026

Patient-centred education for ketamine and esketamine therapies in mood disorders

Zofia Kachlik, Wiesław Jerzy Cubała, Michał Walaszek

Therapeutic Advances in Psychopharmacology